[1] |
苏露,胡金诺,周静,等. 我国居民死因分析研究现状[J]. 现代医药卫生,2018, 34(19): 3011-3014.
|
[2] |
张巍,顾岩. 细胞凋亡与肿瘤化疗的研究进展[J]. 医学综述,2013, 19(3): 451-453.
|
[3] |
戴菁池,曹明富. 抗肿瘤药物诱导细胞凋亡的分子机制研究进展[J]. 杭州师范学院学报(医学版), 2007, 27(1): 53-57.
|
[4] |
于金玉,史小荣,李娟. 凋亡抑制蛋白XIAP与卵巢癌细胞耐药性[J]. 国际妇产科学杂志,2016, 43(2): 161-164.
|
[5] |
Nestal de Moraes G, Delbue D, Silva KL, et al. FOXM1 targets XIAP and survivin to modulate breast cancer survival and chemoresistance[J]. Cell Signal, 2015, 27(12): 2496-2505.
|
[6] |
周卓,李佳,张千锋,等. HSF1与XAF1基因在子宫内膜癌组织中的表达及其相关性分析[J]. 西安交通大学学报(医学版), 2015, 36(2): 231-234.
|
[7] |
赵文静,王学梅,邓博雅,等. XAF1和XIAP在卵巢上皮性癌中的表达及意义[J]. 解剖科学进展,2015, 21(3): 275-278.
|
[8] |
杨静,王祥珍,薛盼,等. 抑癌基因XAF1在宫颈癌组织中的表达变化及临床价值探究[J].中国妇幼卫生杂志,2018, 9(3): 39-41.
|
[9] |
赵文静. XAF1在卵巢癌中的表达及其在卵巢癌细胞顺铂耐药中的研究[D]. 沈阳:中国医科大学,2013.
|
[10] |
Crook NE, Clem RJ, Miller LK. An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif [J]. J Virol, 1993, 67(4): 2168-2174.
|
[11] |
Schimmer AD, Dalili S, Batey RA, et al. Targeting XIAP for the treatment of malignancy[J]. Cell Death Differ, 2006, 13(2): 179-188.
|
[12] |
陈晨,李冉红,刘辉. X-连锁凋亡抑制蛋白基因与卵巢癌化疗药物耐药关系的研究进展[J/CD]. 中华妇幼临床医学杂志(电子版), 2016, 12(1): 104-107.
|
[13] |
Liston P, Fong WG, Kelly NL, et al. Identification of XAF1 as an antagonist of XIAP anti-Caspase activity[J]. Nat Cell Biol, 2001, 3(2): 128-133.
|
[14] |
陈为,王善林,周龙书,等. X染色体连锁凋亡抑制蛋白在宫颈鳞癌组织中的表达及其与新辅助化疗耐药的关系[J]. 中国肿瘤临床与康复,2013, 20(7): 687-689.
|
[15] |
闫红,吴正升,江冬瑞,等. 乳腺癌中自噬相关基因LC3与凋亡相关基因XIAP的表达及意义[J]. 临床与实验病理学杂志,2016, 32(4): 409-412.
|
[16] |
Augeri DJ, Langenfeld E, Castle M, et al. Inhibition of BMP and of TGFβ receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death[J]. Mol Cancer, 2016, 15(1): 27.
|
[17] |
Zhang X, Huang LN, Zhao YL, et al. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly[J]. Acta Biochim Biophys Sin (Shanghai), 2013, 45(12): 995-1001.
|
[18] |
Flanagan L, Kehoe J, Fay J, et al. High levels of X-linked inhibitor-of-apoptosis protein (XIAP) are indicative of radio chemotherapy resistance in rectal cancer[J]. Radiat Oncol, 2015, 10: 131.
|
[19] |
Danson S, Dean E, Dive C, et al. IAPs as a target for anticancer therapy[J]. Curr Cancer Drug Targets, 2007, 7(8): 785-794.
|
[20] |
申薇,梁冰锋,李秀荣,等. 卵巢癌耐药细胞株SKOV3/DDP的建立及其与凋亡途径蛋白的关系[J]. 河北医科大学学报,2014, 35(10): 1135-1139.
|
[21] |
岳驰,李冉红,陈晨,等. XIAP基因与耐紫杉醇卵巢癌细胞A2780/Taxol耐药关系的研究[J]. 四川大学学报(医学版), 2018, 49(3): 337-341.
|
[22] |
Yin D, Wang N, Zhang SL, et al. Specific siRNA inhibits XIAP expression in human endometrial carcinoma cell apoptosis[J]. Cell Biochem Biophys, 2015, 71(1): 161-165.
|
[23] |
Schluckebier L, Aran V, De Moraes J, et al. XAF1 expression levels in a non-small cell lung cancer cohort and its potential association with carcinogenesis[J]. Oncol Rep, 2017, 38(1): 402-410.
|
[24] |
Chen YB, Shu J, Yang WT, et al. XAF1 as a prognostic biomarker and therapeutic target in squamous cell lung cancer[J]. Chin Med J, 2011, 124(20): 3238-3243.
|
[25] |
Ling ZQ, Lv P, Lu XX, et al. Circulating methylated XAF1 DNA indicates poor prognosis for gastric cancer[J]. PLoS One, 2013, 8(6): e67195.
|
[26] |
黄佳,姚玮艳. XAF1在胰腺癌中表达的临床意义及其与患者预后的关系[J]. 中华胰腺病杂志,2015, 15(2): 81-84.
|
[27] |
Zhao WJ, Deng BY, Wang XM, et al. XIAP associated factor 1 (XAF1) represses expression of X-linked inhibitor of apoptosis protein (XIAP) and regulates invasion, cell cycle, apoptosis, and cisplatin sensitivity of ovarian carcinoma cells[J]. Asian Pac J Cancer Prev, 2015, 16(6): 2453-2458.
|
[28] |
Holcik M, Gibson H, Korneluk RG. XIAP: apoptotic brake and promising therapeutic target[J]. Apoptosis, 2001, 6(4): 253-261.
|
[29] |
Zaidi SIH, 段善州, 陈勇兵,等. 肿瘤抑制基因XAF1在耐药肺腺癌细胞中表达的初步研究[J]. 中国保健营养(中旬刊), 2013, 24(3): 38-39.
|